Category VIEW ALL
Biomimetic Nanofibers Electrospun with Calreticulin as Wound Healing Agents
Technology No. GOL01-10
Mutant-Selective HER2 Antibodies for Treatment of Major Cancer Types
Technology No. KOI01-08
Sindbis Virus-Based Vectors for the Oncolytic Immunotherapy of Solid Tumors
Technology No. MER02-24
Monoclonal Antibodies for Efficient Removal of Uremic Toxins in Chronic Kidney Disease Patients
Technology No. KON02-10
Apoptosis Inhibitor 5 (API5)-based Therapeutic for the Treatment of Inflammatory Bowel Diseases
Technology No. CAD01-05
Selective KRAS(G12D)-Binding Monobodies for the Treatment of Cancer
Technology No. KOI01-07
Selective NRAS-Binding Monobodies for the Treatment of Cancer
Technology No. KOI01-10
Novel Probiotic Compositions for Improving Metabolism and Immunity
Technology No. BLA02-12
Therapeutic Hyaluronic Acid and Peptide Composition for Regenerative Repair of Cartilage Injury
Technology No. COW02-02
Injectable Therapeutic Hydrogel for the Treatment of Post-Traumatic Osteoarthritis
Technology No. LIU02-02, MON02-04
Hydrophobically Interspaced, Charged Peptides for the Treatment and Prevention of Dementia
Technology No. WIS02-26
Anti-CD97 Antibody-Drug Conjugates for the Treatment of AML and GBM
Technology No. KOI01-16
High-Throughput Design and Engineering of Mammalian Cells
Technology No. TRO02-01
Vectored ACE2 Receptor Decoy for Prevention and Treatment of Pan-Coronavirus Infections
Technology No. LAN02-06
Targeting the SARS-CoV-2 Viral-Immune Interaction for COVID-19 Therapy
Technology No. WAN05-01
Engineered Progranulin: A Promising Therapeutic Approach for Autoimmune Diseases
Technology No. LIU02-03
Multivalent Steroid Conjugates for Treatment of Castration-Resistant Prostate Cancer (CRPC)
Technology No. KIR01-10
Netrin-1 and UNC5B as Novel Targets in Metabolic Liver Diseases: NAFLD & NASH
Technology No. MOO02-06
FGF23 Ligand Trap: New Biologic for Treating Kidney Diseases
Technology No. MOH01-02
Chimeric FGF21: Treatment of NAFLD, NASH and Hepatic Steatosis
Technology No. MOH01-03
Angiotensin-Converting Enzyme 2 (ACE2) Immunoadhesin Microbody
Technology No. LAN02-03
